Want to see TSE:MSCL full AI Analyst Report?
Satellos Bioscience (MSCL) Income Statement
Satellos Bioscience Income Statement
Last quarter (Q2 2026), Satellos Bioscience's total revenue was $0.00. In Q2, Satellos Bioscience's net income was $-12.09M. See Satellos Bioscience’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 25 | Dec 24 | Dec 23 | Mar 23 | Mar 22 |
|---|---|---|---|---|---|
| $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | |
| $ -5.09K | $ -20.00K | $ -8.82M | $ -3.73M | $ -165.69K | |
| $ 26.92M | $ 27.79M | $ 15.46M | $ 4.69M | $ 4.70M | |
| Depreciation and Amortization | $ 4.00K | $ 20.00K | $ 7.00K | $ 337.00K | $ 165.69K |
| $ -26.92M | $ -28.08M | $ -15.71M | $ -8.09M | $ -4.69M | |
| $ -26.92M | $ -27.81M | $ -15.46M | $ -8.43M | $ -6.65M | |
| $ 1.79M | $ -291.00K | $ -426.00K | $ -2.89M | $ -8.86M | |
| $ -25.13M | $ -28.10M | $ -15.89M | $ -11.32M | $ -15.51M | |
| $ -25.31M | $ -28.10M | $ -15.89M | $ -11.32M | $ -15.51M | |
| Per Share Metrics | |||||
| Basic EPS | $ -1.73 | $ -2.94 | $ -2.21 | $ -3.81 | $ -7.73 |
| Diluted EPS | $ -1.73 | $ -2.94 | $ -2.21 | $ -3.81 | $ -7.73 |
| Weighted Average Shares Outstanding | 14.60M | 9.56M | 7.20M | 2.97M | 2.01M |
| Weighted Average Shares Outstanding (Diluted) | 14.60M | 9.56M | 7.20M | 2.97M | 2.01M |
Currency in CAD
